Literature DB >> 12867477

Microarray transcription analysis of clinical Staphylococcus aureus isolates resistant to vancomycin.

Emmanuel Mongodin1, Jon Finan, Michael W Climo, Adriana Rosato, Steven Gill, Gordon L Archer.   

Abstract

The transcriptomes of vancomycin intermediate-resistance Staphylococcus aureus (VISA) clinical isolates HIP5827 and Mu50 (MIC = 8 micro g/ml) were compared to those of highly vancomycin-resistant S. aureus (VRSA; MIC = 32 micro g/ml) passage derivatives by microarray. There were 35 genes with increased transcription and 16 genes with decreased transcription in common between the two VRSAs compared to those of their VISA parents. Of the 35 genes with increased transcription, 15 involved purine biosynthesis or transport, and the regulator (purR) of the major purine biosynthetic operon (purE-purD) was mutant. We hypothesize that increased energy (ATP) is required to generate the thicker cell walls that characterize resistant mutants.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12867477      PMCID: PMC165753          DOI: 10.1128/JB.185.15.4638-4643.2003

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  20 in total

1.  Significance analysis of microarrays applied to the ionizing radiation response.

Authors:  V G Tusher; R Tibshirani; G Chu
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-17       Impact factor: 11.205

2.  Gradual alterations in cell wall structure and metabolism in vancomycin-resistant mutants of Staphylococcus aureus.

Authors:  K Sieradzki; A Tomasz
Journal:  J Bacteriol       Date:  1999-12       Impact factor: 3.490

3.  From the Centers for Disease Control and Prevention. Staphylococcus aureus with reduced susceptibility to vancomycin--Illinois, 1999.

Authors: 
Journal:  JAMA       Date:  2000-02-02       Impact factor: 56.272

4.  Inactivated pbp4 in highly glycopeptide-resistant laboratory mutants of Staphylococcus aureus.

Authors:  K Sieradzki; M G Pinho; A Tomasz
Journal:  J Biol Chem       Date:  1999-07-02       Impact factor: 5.157

Review 5.  Staphylococcal infections in the intensive care unit.

Authors:  W McGahee; F D Lowy
Journal:  Semin Respir Infect       Date:  2000-12

6.  Staphylococcus aureus with reduced susceptibility to vancomycin--Illinois, 1999.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2000-01-07       Impact factor: 17.586

7.  Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50.

Authors:  L Cui; H Murakami; K Kuwahara-Arai; H Hanaki; K Hiramatsu
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

8.  Mutations in the Bacillus subtilis purine repressor that perturb PRPP effector function in vitro and in vivo.

Authors:  M Weng; H Zalkin
Journal:  Curr Microbiol       Date:  2000-07       Impact factor: 2.188

9.  Accessory gene regulator (agr) locus in geographically diverse Staphylococcus aureus isolates with reduced susceptibility to vancomycin.

Authors:  George Sakoulas; George M Eliopoulos; Robert C Moellering; Christine Wennersten; Lata Venkataraman; Richard P Novick; Howard S Gold
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

10.  Role of penicillin-binding protein 4 in expression of vancomycin resistance among clinical isolates of oxacillin-resistant Staphylococcus aureus.

Authors:  J E Finan; G L Archer; M J Pucci; M W Climo
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

View more
  64 in total

1.  Whole-genome expression profiling of Thermotoga maritima in response to growth on sugars in a chemostat.

Authors:  Tu N Nguyen; Arvin D Ejaz; Mark A Brancieri; Amy M Mikula; Karen E Nelson; Steven R Gill; Kenneth M Noll
Journal:  J Bacteriol       Date:  2004-07       Impact factor: 3.490

2.  Cell wall composition and decreased autolytic activity and lysostaphin susceptibility of glycopeptide-intermediate Staphylococcus aureus.

Authors:  Jennifer L Koehl; Arunachalam Muthaiyan; Radheshyam K Jayaswal; Kerstin Ehlert; Harald Labischinski; Brian J Wilkinson
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

3.  Using chemical derivatization and mass spectrometric analysis to characterize the post-translationally modified Staphylococcus aureus surface protein G.

Authors:  Moo-Jin Suh; David J Clark; Prashanth P Parmer; Robert D Fleischmann; Scott N Peterson; Rembert Pieper
Journal:  Biochim Biophys Acta       Date:  2010-02-20

4.  Isolates with low-level vancomycin resistance associated with persistent methicillin-resistant Staphylococcus aureus bacteremia.

Authors:  Benjamin P Howden; Paul D R Johnson; Peter B Ward; Timothy P Stinear; John K Davies
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

5.  Transcriptomic and functional analysis of an autolysis-deficient, teicoplanin-resistant derivative of methicillin-resistant Staphylococcus aureus.

Authors:  Adriana Renzoni; Christine Barras; Patrice François; Yvan Charbonnier; Elzbieta Huggler; Christian Garzoni; William L Kelley; Paul Majcherczyk; Jacques Schrenzel; Daniel P Lew; Pierre Vaudaux
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

6.  The msaABCR operon regulates resistance in vancomycin-intermediate Staphylococcus aureus strains.

Authors:  Dhritiman Samanta; Mohamed O Elasri
Journal:  Antimicrob Agents Chemother       Date:  2014-08-25       Impact factor: 5.191

Review 7.  Low-level vancomycin resistance in Staphylococcus aureus--an Australian perspective.

Authors:  B P Howden; P B Ward; P D R Johnson; P G P Charles; M L Grayson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-02       Impact factor: 3.267

8.  Novel mechanism of antibiotic resistance originating in vancomycin-intermediate Staphylococcus aureus.

Authors:  Longzhu Cui; Akira Iwamoto; Jian-Qi Lian; Hui-min Neoh; Toshiki Maruyama; Yataro Horikawa; Keiichi Hiramatsu
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

9.  Responses of wild-type and resistant strains of the hyperthermophilic bacterium Thermotoga maritima to chloramphenicol challenge.

Authors:  Clemente I Montero; Matthew R Johnson; Chung-Jung Chou; Shannon B Conners; Sarah G Geouge; Sabrina Tachdjian; Jason D Nichols; Robert M Kelly
Journal:  Appl Environ Microbiol       Date:  2007-06-08       Impact factor: 4.792

10.  Staphylococcus aureus biofilm metabolism and the influence of arginine on polysaccharide intercellular adhesin synthesis, biofilm formation, and pathogenesis.

Authors:  Yefei Zhu; Elizabeth C Weiss; Michael Otto; Paul D Fey; Mark S Smeltzer; Greg A Somerville
Journal:  Infect Immun       Date:  2007-06-18       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.